PD-L1 His Tag Protein, Human
PD-L1 His Tag Protein, Human
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | Programmed cell death 1 ligand 1, CD274, B7-H1, Programmed death ligand 1 |
| Accession | Q9NZQ7 |
| Amino Acid Sequence | Phe19-Arg238, with C-terminal His Tag |
| Expression System | HEK293 |
| Molecular Weight | 30-35 KD(Reducing) |
| Purity | ＞95%, by SDS-PAGE under reducing conditions |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, pH 7.2,5% trehalose |
| Reconstitution | Reconstitute at less than 1 mg/mL according to the size in ultrapure water after rapid centrifugation . |
| Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Background
PD-L1, also known as B7-H1 and CD274, is a 290 amino acid transmembrane glycoprotein in the B7 family of immune regulatory molecules. It has an extracellular domain that can interact with PD-1, which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. The PD1/PD-L1 interaction ensures that activation of the immune system occurs at the appropriate time. This will minimize the possibility of chronic autoimmune inflammation. PD-L1 is known to inhibit proliferation of T cells via apoptosis. It also plays an important role in arresting cell-cycle progression. This makes PD-L1 an attractive therapeutic target for cancer and immunologic diseases.
Picture
Picture
Bioactivity
SDS-PAGE
ELISA
Immobilized PD-L1 His Tag Protein, Human (Cat. No. UA010001) at 1.0μg/mL (100μL/well) can bind S-RMab® PD-L1 Recombinant Rabbit mAb (SDT-119-286) (Cat. No. S0B2287) with EC50 of 0.89-1.21ng/mL.
